Study on the carboxymethyl chitosan oligosaccharide effect of rats models with Alzheimer’s disease

liu guijuan,li zhuoyue,shi jie,jiang zhiwen,he ming,liu wanshun,han baoqin
DOI: https://doi.org/10.13400/j.cnki.cjmd.2015.05.005
2015-01-01
Abstract:Objective To investigate the effect and mechanism of carboxymethyl chitosan oligosaccharide on Alzheimers disease model rats.Methods Aβ25-35 was injected into the rats lateral ventricle to make AD models.Using the different doses of carboxymethyl chitosan oligosaccharide(CM-COS)respectively,the model group rats were intragastric administration therapy.After intragastric administration for 4weeks,the learning and memory ability of rats were tested with Morris water labyrinth.To determine the role of CM-COS on the effect and mechanism of AD rat,the content of MDA,A-CHE,SOD,CHAT and GSH-PX in the rats hippocampal tissue were measured.Results CM-COS could significantly decrease the content of MDA and A-CHE in hippocampus of animal models and could significantly increase the content of SOD,CHAT and GSH-PX.Morris water labyrinth experiment results showed that carboxymethyl chitosan oligosaccharide could significantly shorten the animal escape latency time and increase the number of cross platform.Conclusion CM-COS in hippocampal tissue could improvetheability of learning and memory in AD rats by increasing the antioxidant capacity and improving the cholinergic system,and had a certain therapeutic effect on Aβ25-35 caused by Alzheimer’s disease.
What problem does this paper attempt to address?